Celldex Therapeutics (CLDX) Assets (2016 - 2025)
Historic Assets for Celldex Therapeutics (CLDX) over the last 16 years, with Q3 2025 value amounting to $648.4 million.
- Celldex Therapeutics' Assets fell 2122.75% to $648.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $648.4 million, marking a year-over-year decrease of 2122.75%. This contributed to the annual value of $792.3 million for FY2024, which is 7016.62% up from last year.
- Latest data reveals that Celldex Therapeutics reported Assets of $648.4 million as of Q3 2025, which was down 2122.75% from $692.4 million recorded in Q2 2025.
- In the past 5 years, Celldex Therapeutics' Assets registered a high of $868.8 million during Q1 2024, and its lowest value of $204.6 million during Q2 2021.
- In the last 5 years, Celldex Therapeutics' Assets had a median value of $444.7 million in 2021 and averaged $508.3 million.
- In the last 5 years, Celldex Therapeutics' Assets plummeted by 2572.21% in 2023 and then surged by 19372.4% in 2024.
- Quarter analysis of 5 years shows Celldex Therapeutics' Assets stood at $444.7 million in 2021, then dropped by 20.67% to $352.7 million in 2022, then skyrocketed by 32.0% to $465.6 million in 2023, then surged by 70.17% to $792.3 million in 2024, then dropped by 18.16% to $648.4 million in 2025.
- Its last three reported values are $648.4 million in Q3 2025, $692.4 million for Q2 2025, and $739.5 million during Q1 2025.